Palijativno zbrinjavanje obolelih od Parkinsonove bolesti

Branimirka Aranđelović; Svetlana Simić; Slobodanka  Bogdanović Vasić; Milena Mikić; Jovana Uzelac; Sandra Glamočak

doi:10.5937/pomc20-47261

Branimirka Aranđelović Univerzitet u Novom Sadu Medicinski fakultet Katedra za zdravstvenu negu https://orcid.org/0000-0001-5768-8668
Svetlana Simić Univerzitet u Novom Sadu, Medicinski fakultet, Katedra za neurologiju, Novi Sad https://orcid.org/0000-0003-1857-8209
Slobodanka Bogdanović Vasić Akademija strukovnih studija Šabac, Odsek za medicinske i poslovno-tehnološke studije, Šabac
Milena Mikić Univerzitet u Novom Sadu, Medicinski fakultet, Katedra za zdravstvenu negu, Novi Sad https://orcid.org/0000-0001-8146-1308
Jovana Uzelac Univerzitet u Novom Sadu, Medicinski fakultet, Katedra za specijalnu edukaciju i rehabilitaciju, Novi Sad
Sandra Glamočak Univerzitet u Novom Sadu, Medicinski fakultet, Katedra za specijalnu edukaciju i rehabilitaciju, Novi Sad

DOI: https://doi.org/10.5937/pomc20-47261

Ključne reči: palijativno zbrinjavanje; Parkinsonova bolest; znaci i simptomi; multidisciplinarni tim

Sažetak

Parkinsonova bolest je hronična, progresivna, neurodegenerativna bolest od koje najčešće oboljevaju osobe starije životne dobi. Bolest karakteriše širok dijapazon motornih i nemotornih simptoma koji napredovanjem bolesti dovode do značajnog invaliditeta, zavisnosti od drugih osoba i narušenog kvaliteta života. Trenutno ne postoji lek koji može izlečiti ili zaustaviti progresiju bolesti. Palijativnim zbrinjavanjem uz holistički pristup i uključivanjem multidisciplinarnog tima većina simptoma se može držati pod kontrolom i pružiti podrška negovateljima što značajno doprinosi boljem kvalitetu života kako obolelih tako i njihovih porodica odnosno negovatelja.

Reference

1. Chen Y, Zhang R, Lou Y, Li W, Yang H. Facilitators and barriers to the delivery of palliative care to patients with Parkinson's disease: a qualitative study of the perceptions and experiences of stakeholders using the socio-ecological model. BMC Health Serv Res 2023; 23(1): 215.

2. Simon DK, Tanner CM, Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 2020; 36(1): 1-12.

3. Oliver D, Veronese S. Specialist palliative care for Parkinson's disease. Ann Palliat Med 2020; 9(Suppl 1): S52-S62.

4. Katz M. Palliative care for Parkinson's spectrum disorders: an emerging approach. Neurotherapeutics 2020; 17(4): 1456-63.

5. Lum HD, Kluger BM. Palliative care for Parkinson disease. Clin Geriatr Med 2020; 36(1): 149-57.

6. Ng JSC. Palliative care for Parkinson's disease. Ann Palliat Med 2018; 7(3): 296-303.

7. Wang Z, Wang Y, Wang ZY, et al. Palliative care for Parkinson’s disease patients and their caregivers. Life Res 2022; 5(2): 4.

8. Post B, van den Heuvela L, van Prooijea T, van Ruissena X, van de Warrenburga B, Nonnekesb J. Young onset Parkinson’s disease: a modern and tailored approach. J Parkinsons Dis 2020; 10: S29–S36.

9. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA 2020; 323(6): 548-60.

10. World Health Organization. Parkinson disease. Geneva: World Health Organization, 2023. (https://www.who.int/news-room/fact-sheets/detail/parkinson-disease).

11. Massano J, Bhatia KP. Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2012; 2(6): a008870.

12. Tarakad A, Jankovic J. Diagnosis and management of Parkinson's disease. Semin Neurol 2017; 37(2): 118-26.

13. Moustafa AA, Chakravarthy S, Phillips JR, et al. Motor symptoms in Parkinson's disease: a unified framework. Neurosci Biobehav Rev 2016; 68: 727-40.

14. Chakraborty A, Brauer S, Diwan A. A review of possible therapies for Parkinson's disease. J Clin Neurosci 2020; 76: 1-4.

15. Provinciali L, Carlini G, Tarquini D, Defanti CA, Veronese S, Pucci E. Need for palliative care for neurological diseases. Neurol Sci 2016; 37(10): 1581-7.

16. Radbruch L, Payne S. White Paper on standards and norms for hospice and palliative care in Europe: part 1. Recommendations from the European association for palliative care. Eur J Palliat Care 2009; 16(6): 278-89. http://www.thewhpca.org/images/resources/npsg/Radbruch%202009%20EAPC%20White%20~standards%20part1%20EJPC.pdf

17. World Health Organization. Palliative care. Geneva: World Health Organization, 2020. (https://www.who.int/news-room/fact-sheets/detail/palliative-care).

18. Taylor LP, Besbris JM, Graf WD, Rubin MA, Cruz-Flores S, Epstein LG. Ethics, law, and humanities committee, a joint committee of the American academy of neurology, American neurological association, and Child neurology society. Clinical guidance in neuropalliative care: an AAN position statement. Neurology 2022; 98(10): 409-16.

19. Lokk J, Delbari A. Clinical aspects of palliative care in advanced Parkinson's disease. BMC Palliat Care 2012; 11: 20.

20. Fleisher JE, Klostermann EC, Hess SP, Lee J, Myrick E, Chodosh J. Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home. Ann Palliat Med 2020; 9(Suppl 1): S80-S89.

21. Gabriel LB, Rossetto EM, Martins VB, Berbert MCB. Speech therapy aspects in patients’ palliative care. Rev. CEFAC 2021; 23(6): e10421.

22. van der Marck MA, Kalf JG, Faber MJ, Bloem BR. Nonpharmacologic multidisciplinary approach to the treatment of Parkinson’s disease. In: Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders. 6th ed. Philadelphia: Wolters Kluwer, 2015: 1322-44.

23. Chaudhuri KR, Bhidayasiri R, van Laar T. Unmet needs in Parkinson's disease: new horizons in a changing landscape. Parkinsonism Relat Disord 2016; 33 Suppl 1: S2-S8.

24. Wichmann, R. Role of physical therapy in management of Parkinson’s disease. In: Pfeiffer RF, Wszolek ZK, Ebadi M, eds. Parkinson’s disease. 2nd ed. Boca Raton: Taylor and Francis Group, 2013: 937-44.

25. Campbell CW, Jones EJ, Merrills J. Palliative and end-of-life care in advanced Parkinson's disease and multiple sclerosis. Clin Med (Lond). 2010 Jun;10(3):290-2. doi: 10.7861/clinmedicine.10-3-290. PMID: 20726466; PMCID: PMC5873561.

26. Chou KL, Hurtig HI. Tremor, rigidity, and bradykinesia. In: Pfeiffer RF, Wszolek ZK, Ebadi M, eds. Parkinson’s disease. 2nd ed. Boca Raton: Taylor and Francis Group, 2013: 191-201.

27. Rana AQ, Ahmed US, Chaudry ZM, Vasan S. Parkinson's disease: a review of non-motor symptoms. Expert Rev Neurother 2015; 15(5): 549-62.

28. Aarsland D, Steenoven IV, Taylor JP, et al. Neuropsychiatric aspects of Parkinson’s disease. In Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders. 6th ed. Philadelphia: Wolters Kluwer, 2015: 370-95.

29. Pfeiffer RF. Non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2016; 22 Suppl 1: S119-22.

30. Perez-Lloret S. Clinical trials in Parkinson's disease. New York: Humana Press, 2021.

31. Pedrosa Carrasco AJ, Timmermann L, Pedrosa DJ. Management of constipation in patients with Parkinson's disease. NPJ Parkinsons Dis 2018; 4: 6.

32. Nair, S. Palliative care in neurological diseases. In: Prabhakar H, Zulfiqar AZ, eds. Textbook of neuroanesthesia and neurocritical care. Singapore: Springer Nature Singapore, 2019: 277-95.

33. Halper J, Holland NJ, eds. Comprehensive nursing care in multiple sclerosis. 3rd. ed. New York: Springer Publishing Company, 2011.

34. Sveinbjornsdottir S. The clinical symptoms of Parkinson's disease. J Neurochem 2016; 139 Suppl 1: 318-24.

35. van Gerpen JA, Castillo P. Insomnia and excessive daytime sleepiness in Parkinson’s disease. In Pfeiffer RF, Wszolek ZK, Ebadi M, eds. Parkinson’s disease. 2nd ed. Boca Raton: Taylor and Francis Group, 2013: 291-300.

36. Videnovic A, Comella CL. REM sleep behavior disorder. In: Pfeiffer RF, Wszolek ZK, Ebadi M, eds. Parkinson’s disease. 2nd ed. Boca Raton: Taylor and Francis Group, 2013: 301-08.

37. Santamaria J. Sleep and fatigue in Parkinson’s disease. In Jankovic J, Tolosa E, eds. Parkinson’s disease and movement disorders. 6th ed. Philadelphia: Wolters Kluwer, 2015: 1084-110.

38. Rosiak K, Zagożdżon P. Quality of life and social support in patients with multiple sclerosis. Psychiatr Pol 2017; 51(5): 923-35.

39. Robinson MT, Holloway RG. Palliative care in neurology. Mayo Clin Proc 2017; 92(10): 1592-601.

40. Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis N, Miyasaki JM. Correlates of spiritual wellbeing in persons living with Parkinson disease. Ann Palliat Med 2020; 9(Suppl 1): S16-S23.

41. Sokol LL, Young MJ, Paparian J, et al. Advance care planning in Parkinson's disease: ethical challenges and future directions. NPJ Parkinsons Dis 2019; 5:24.

42. Lennaerts H, Steppe M, Munneke M, et al. Palliative care for persons with Parkinson's disease: a qualitative study on the experiences of health care professionals. BMC Palliat Care 2019; 18(1): 53.